Cargando…
Real-World Diagnostic Accuracy and Use of Immunohistochemical Markers in Lung Cancer Diagnostics
Objectives: Accurate and reliable diagnostics are crucial as histopathological type influences selection of treatment in lung cancer. The aim of this study was to evaluate real-world accuracy and use of immunohistochemical (IHC) staining in lung cancer diagnostics. Materials and Methods: The diagnos...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615395/ https://www.ncbi.nlm.nih.gov/pubmed/34827719 http://dx.doi.org/10.3390/biom11111721 |
_version_ | 1784604094225186816 |
---|---|
author | Ericson Lindquist, Kajsa Gudinaviciene, Inga Mylona, Nektaria Urdar, Rodrigo Lianou, Maria Darai-Ramqvist, Eva Haglund, Felix Béndek, Mátyás Bardoczi, Erika Dobra, Katalin Brunnström, Hans |
author_facet | Ericson Lindquist, Kajsa Gudinaviciene, Inga Mylona, Nektaria Urdar, Rodrigo Lianou, Maria Darai-Ramqvist, Eva Haglund, Felix Béndek, Mátyás Bardoczi, Erika Dobra, Katalin Brunnström, Hans |
author_sort | Ericson Lindquist, Kajsa |
collection | PubMed |
description | Objectives: Accurate and reliable diagnostics are crucial as histopathological type influences selection of treatment in lung cancer. The aim of this study was to evaluate real-world accuracy and use of immunohistochemical (IHC) staining in lung cancer diagnostics. Materials and Methods: The diagnosis and used IHC stains for small specimens with lung cancer on follow-up resection were retrospectively investigated for a 15-month period at two major sites in Sweden. Additionally, 10 pathologists individually suggested diagnostic IHC staining for 15 scanned bronchial and lung biopsies and cytological specimens. Results: In 16 (4.7%) of 338 lung cancer cases, a discordant diagnosis of potential clinical relevance was seen between a small specimen and the follow-up resection. In half of the cases, there was a different small specimen from the same investigational work-up with a concordant diagnosis. Diagnostic inaccuracy was often related to a squamous marker not included in the IHC panel (also seen for the scanned cases), the case being a neuroendocrine tumor, thyroid transcription factor-1 (TTF-1) expression in squamous cell carcinomas (with clone SPT24), or poor differentiation. IHC was used in about 95% of cases, with a higher number of stains in biopsies and in squamous cell carcinomas and especially neuroendocrine tumors. Pre-surgical transthoracic samples were more often diagnostic than bronchoscopic ones (72–85% vs. 9–53% for prevalent types). Conclusions: Although a high overall diagnostic accuracy of small specimens was seen, small changes in routine practice (such as consequent inclusion of p40 and TTF-1 clone 8G7G3/1 in the IHC panel for non-small cell cancer with unclear morphology) may lead to improvement, while reducing the number of IHC stains would be preferable from a time and cost perspective. |
format | Online Article Text |
id | pubmed-8615395 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86153952021-11-26 Real-World Diagnostic Accuracy and Use of Immunohistochemical Markers in Lung Cancer Diagnostics Ericson Lindquist, Kajsa Gudinaviciene, Inga Mylona, Nektaria Urdar, Rodrigo Lianou, Maria Darai-Ramqvist, Eva Haglund, Felix Béndek, Mátyás Bardoczi, Erika Dobra, Katalin Brunnström, Hans Biomolecules Article Objectives: Accurate and reliable diagnostics are crucial as histopathological type influences selection of treatment in lung cancer. The aim of this study was to evaluate real-world accuracy and use of immunohistochemical (IHC) staining in lung cancer diagnostics. Materials and Methods: The diagnosis and used IHC stains for small specimens with lung cancer on follow-up resection were retrospectively investigated for a 15-month period at two major sites in Sweden. Additionally, 10 pathologists individually suggested diagnostic IHC staining for 15 scanned bronchial and lung biopsies and cytological specimens. Results: In 16 (4.7%) of 338 lung cancer cases, a discordant diagnosis of potential clinical relevance was seen between a small specimen and the follow-up resection. In half of the cases, there was a different small specimen from the same investigational work-up with a concordant diagnosis. Diagnostic inaccuracy was often related to a squamous marker not included in the IHC panel (also seen for the scanned cases), the case being a neuroendocrine tumor, thyroid transcription factor-1 (TTF-1) expression in squamous cell carcinomas (with clone SPT24), or poor differentiation. IHC was used in about 95% of cases, with a higher number of stains in biopsies and in squamous cell carcinomas and especially neuroendocrine tumors. Pre-surgical transthoracic samples were more often diagnostic than bronchoscopic ones (72–85% vs. 9–53% for prevalent types). Conclusions: Although a high overall diagnostic accuracy of small specimens was seen, small changes in routine practice (such as consequent inclusion of p40 and TTF-1 clone 8G7G3/1 in the IHC panel for non-small cell cancer with unclear morphology) may lead to improvement, while reducing the number of IHC stains would be preferable from a time and cost perspective. MDPI 2021-11-18 /pmc/articles/PMC8615395/ /pubmed/34827719 http://dx.doi.org/10.3390/biom11111721 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ericson Lindquist, Kajsa Gudinaviciene, Inga Mylona, Nektaria Urdar, Rodrigo Lianou, Maria Darai-Ramqvist, Eva Haglund, Felix Béndek, Mátyás Bardoczi, Erika Dobra, Katalin Brunnström, Hans Real-World Diagnostic Accuracy and Use of Immunohistochemical Markers in Lung Cancer Diagnostics |
title | Real-World Diagnostic Accuracy and Use of Immunohistochemical Markers in Lung Cancer Diagnostics |
title_full | Real-World Diagnostic Accuracy and Use of Immunohistochemical Markers in Lung Cancer Diagnostics |
title_fullStr | Real-World Diagnostic Accuracy and Use of Immunohistochemical Markers in Lung Cancer Diagnostics |
title_full_unstemmed | Real-World Diagnostic Accuracy and Use of Immunohistochemical Markers in Lung Cancer Diagnostics |
title_short | Real-World Diagnostic Accuracy and Use of Immunohistochemical Markers in Lung Cancer Diagnostics |
title_sort | real-world diagnostic accuracy and use of immunohistochemical markers in lung cancer diagnostics |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615395/ https://www.ncbi.nlm.nih.gov/pubmed/34827719 http://dx.doi.org/10.3390/biom11111721 |
work_keys_str_mv | AT ericsonlindquistkajsa realworlddiagnosticaccuracyanduseofimmunohistochemicalmarkersinlungcancerdiagnostics AT gudinavicieneinga realworlddiagnosticaccuracyanduseofimmunohistochemicalmarkersinlungcancerdiagnostics AT mylonanektaria realworlddiagnosticaccuracyanduseofimmunohistochemicalmarkersinlungcancerdiagnostics AT urdarrodrigo realworlddiagnosticaccuracyanduseofimmunohistochemicalmarkersinlungcancerdiagnostics AT lianoumaria realworlddiagnosticaccuracyanduseofimmunohistochemicalmarkersinlungcancerdiagnostics AT darairamqvisteva realworlddiagnosticaccuracyanduseofimmunohistochemicalmarkersinlungcancerdiagnostics AT haglundfelix realworlddiagnosticaccuracyanduseofimmunohistochemicalmarkersinlungcancerdiagnostics AT bendekmatyas realworlddiagnosticaccuracyanduseofimmunohistochemicalmarkersinlungcancerdiagnostics AT bardoczierika realworlddiagnosticaccuracyanduseofimmunohistochemicalmarkersinlungcancerdiagnostics AT dobrakatalin realworlddiagnosticaccuracyanduseofimmunohistochemicalmarkersinlungcancerdiagnostics AT brunnstromhans realworlddiagnosticaccuracyanduseofimmunohistochemicalmarkersinlungcancerdiagnostics |